Clearance Summary
TD-4277 BLOOD GLUCOSE MONITORING SYSTEM, MODEL 4277 received FDA 510(k) clearance under submission number K100322, sponsored by Taidoc Technology Corporation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2010-06-28.
- Submission: K100322
- Applicant / Sponsor: Taidoc Technology Corporation
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1345
- Decision date: 2010-06-28
Classification & Regulation
This clearance is catalogued under FDA product code NBW and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.